Share Price & News
How has Beijing Balance Medical TechnologyLtd's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 688198 is more volatile than 75% of CN stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: 688198's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
7 Day Return
1 Year Return
Return vs Industry: 688198 exceeded the CN Biotechs industry which returned 35.6% over the past year.
Return vs Market: 688198 exceeded the CN Market which returned 27.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Beijing Balance Medical TechnologyLtd's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Beijing Balance Medical TechnologyLtd undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 688198 (CN¥143.05) is trading above our estimate of fair value (CN¥11.6)
Significantly Below Fair Value: 688198 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 688198 is poor value based on its PE Ratio (246.6x) compared to the CN Biotechs industry average (56x).
PE vs Market: 688198 is poor value based on its PE Ratio (246.6x) compared to the CN market (34.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 688198's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 688198 is overvalued based on its PB Ratio (17.1x) compared to the CN Biotechs industry average (6.1x).
How is Beijing Balance Medical TechnologyLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Beijing Balance Medical TechnologyLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Beijing Balance Medical TechnologyLtd performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 688198 has high quality earnings.
Growing Profit Margin: 688198's current net profit margins (30.8%) are lower than last year (43.2%).
Past Earnings Growth Analysis
Earnings Trend: 688198's earnings have grown by 17.3% per year over the past 5 years.
Accelerating Growth: 688198's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688198 had negative earnings growth (-11.1%) over the past year, making it difficult to compare to the Biotechs industry average (16.3%).
Return on Equity
High ROE: 688198's Return on Equity (7%) is considered low.
How is Beijing Balance Medical TechnologyLtd's financial position?
Financial Position Analysis
Short Term Liabilities: 688198's short term assets (CN¥769.4M) exceed its short term liabilities (CN¥19.9M).
Long Term Liabilities: 688198's short term assets (CN¥769.4M) exceed its long term liabilities (CN¥3.8M).
Debt to Equity History and Analysis
Debt Level: 688198 is debt free.
Reducing Debt: 688198 has not had any debt for past 5 years.
Debt Coverage: 688198 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688198 has no debt, therefore coverage of interest payments is not a concern.
What is Beijing Balance Medical TechnologyLtd current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 688198's dividend (0.14%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.42%).
High Dividend: 688198's dividend (0.14%) is low compared to the top 25% of dividend payers in the CN market (1.79%).
Stability and Growth of Payments
Stable Dividend: 688198 is not paying a notable dividend for the CN market, therefore no need to check if payments are stable.
Growing Dividend: 688198 is not paying a notable dividend for the CN market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: 688198 is not paying a notable dividend for the CN market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 688198's dividend in 3 years as they are not forecast to pay a notable one for the CN market.
How experienced are the management team and are they aligned to shareholders interests?
Beijing Balance Medical TechnologyLtd has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Beijing Balance Medical Technology Co.,Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Beijing Balance Medical Technology Co.,Ltd.
- Ticker: 688198
- Exchange: SHSE
- Founded: 2005
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥13.733b
- Shares outstanding: 96.00m
- Website: https://www.bairenmedical.com
Number of Employees
- Beijing Balance Medical Technology Co.,Ltd.
- Science Park
- No. 2, Huachang Road
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, and production of animal-derived implantable medical devices in China. The company offers artificial biological heart va...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/11 09:03|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.